MRC1 and colonic neoplasm: For this analysis, we used MMR proficient (15–63) and deficient pre-B cell lines (8–58: Msh2−/−), and MMR proficient (SW680) and deficient (DLD-1; Msh6-deficient) human colon cancer cell lines.